EFFICACY AND SAFETY OF ZOLEDRONIC ACID 5 MG IN THE PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN WITH OSTEOPENIA: THE HORIZON PREVENTION STUDY

被引:0
|
作者
McClung, Michael R. [1 ]
Miller, Paul [2 ]
Recknor, Christopher [3 ]
Ruzucky, Maryellen [4 ]
BucciRechtweg, Christina [4 ]
Yu, Sue [4 ]
Benhamou, Claude Laurent [5 ]
机构
[1] Oregon Osteoporosis Ctr, Portland, OR USA
[2] Colorado Ctr Bone Res, Lakewood, CO USA
[3] UOC, Gainesville, FL USA
[4] Novartis Pharmaceut, E Hanover, NJ USA
[5] IPROSA Reg Hosp Orleans, Orleans, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S212 / S213
页数:2
相关论文
共 50 条
  • [1] Efficacy and Safety of a Once-Yearly Intravenous Zoledronic Acid 5 mg for Fracture Prevention in Elderly Postmenopausal Women with Osteoporosis Aged 75 and Older
    Boonen, Steven
    Black, Dennis M.
    Colon-Emeric, Cathleen S.
    Eastell, Richard
    Magaziner, Jay S.
    Eriksen, Erik Fink
    Mesenbrink, Peter
    Haentjens, Patrick
    Lyles, Kenneth W.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2010, 58 (02) : 292 - 299
  • [2] EFFICACY AND SAFETY OF ZOLEDRONIC ACID IN CHINESE WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
    Huang, L.
    Shen, Y. H.
    Liu, X.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S820 - S821
  • [3] A PROSPECTIVE STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ZOLEDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
    Sheng, C. Jen
    Chen, W. -J.
    Chang, I. -L.
    Wong, C. -Y.
    Lee, P. -Y.
    Wu, R. -W
    Hsu, S. -K
    Liang, C. -C.
    Shen, P. -W.
    Chang, T. -K
    Lin, M. -Z
    Huang, M. -J.
    Lee, Y. -M
    [J]. OSTEOPOROSIS INTERNATIONAL, 2014, 25 : 629 - 630
  • [4] Zoledronic acid safety and efficacy over 5 years in postmenopausal osteoporosis
    Devogelaer, J. P.
    Burckhardt, P.
    Meunier, P.
    Kaufman, J. M.
    Lippuner, K.
    Body, J. J.
    Samsioe, G.
    Felsenberg, D.
    Brown, J.
    Garnero, P.
    Sanna, L.
    Ortmann, C. E.
    Krasnow, J.
    Eriksen, E.
    Fashola, T. F.
    Trechsel, U.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S213 - S213
  • [5] Renal safety of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis: Results from horizon-PFT
    Miller, Paul
    Sellmeyer, Deborah
    Boonen, Steven R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S227 - S228
  • [6] Renal safety of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis: results from HORIZON-PFT
    Miller, P.
    Sellmeyer, D.
    Boonen, S.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S129 - S130
  • [7] Renal safety of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis: Results from horizon-PFT
    Miller, P.
    Delmas, R.
    Sellmeyer, D.
    Abrams, K.
    Hu, H.
    Lippuner, K.
    Boonen, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 523 - 524
  • [8] Efficacy and safety of bazedoxifene (Viviant) in postmenopausal women with osteoporosis and osteopenia
    Chae, Hee Dong
    Kim, Do-Young
    Kim, Hyun-Jin
    Kim, Sung-Hoon
    Kang, Byung-Moon
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2018, 25 (12): : 1493 - 1494
  • [9] Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis: the horizon pivotal fracture trial
    Black, D. M.
    Delmas, P.
    Eastell, R.
    Reid, I.
    Boonen, S.
    Cauley, J.
    Cosman, F.
    Lakatos, P.
    Leung, P. C.
    Man, Z.
    Eriksen, E. F.
    Mesenbrink, P.
    Hue, T.
    Cummings, S.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S21 - S21
  • [10] THE EFFICACY OF ZOLEDRONIC ACID IN POSTMENOPAUSAL OSTEOPOROSIS
    Peytcheva, Veneta
    Marinchev, Lyubomir
    Kolarov, Zlatimir
    Bekyarova, Penka
    Petranova, Tzvetanka
    Dimitrova, Daniela
    Ivanova, Mariana
    Ivanova, Mariana
    Rashkov, Rasho
    Marinova, Natalia
    Dimitrova, Reneta
    Monov, Simeon
    Garbeva, Kamelia
    Reshkova, Valentina
    Dimitrov, Kalin
    Stoilov, Rumen
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 323 - 324